Sign Up to like & get
recommendations!
2
Published in 2020 at "Journal of medicinal chemistry"
DOI: 10.1021/acs.jmedchem.0c00011
Abstract: Toll-like receptor 7 (TLR7) is an established therapeutic target in myriad autoimmune disorders, but no TLR7 antagonist is available for clinical use to date. Herein we report a purine scaffold TLR7 antagonist, first-of-its-kind to our…
read more here.
Keywords:
toll like;
chemical switch;
like receptor;
clinically relevant ... See more keywords